Clinical Trial Update: BDB-001 Phase III Trial in ANCA-Associated Vasculitis [Phase 3]

View source ↗

Summary

Phase III clinical trial of BDB-001 for ANCA-associated vasculitis is currently recruiting, sponsored by Staidson (Beijing) Biopharmaceuticals Co., Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anca-associated Vasculitis

Drugs mentioned

• BDB-001

Snippet

Sponsor: Staidson (Beijing) Biopharmaceuticals Co., Ltd | Conditions: ANCA Associated Vasculitis (AAV) | Phase 3 | Status: RECRUITING